BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

990 related articles for article (PubMed ID: 25624438)

  • 1. Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer.
    Liang W; Zhang L; Jiang G; Wang Q; Liu L; Liu D; Wang Z; Zhu Z; Deng Q; Xiong X; Shao W; Shi X; He J
    J Clin Oncol; 2015 Mar; 33(8):861-9. PubMed ID: 25624438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic Model.
    Louie AV; Haasbeek CJ; Mokhles S; Rodrigues GB; Stephans KL; Lagerwaard FJ; Palma DA; Videtic GM; Warner A; Takkenberg JJ; Reddy CA; Maat AP; Woody NM; Slotman BJ; Senan S
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):82-90. PubMed ID: 26138912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting prognosis in resected esophageal squamous cell carcinoma using a clinical nomogram and recursive partitioning analysis.
    Zheng Y; Fu S; He T; Yan Q; Di W; Wang J
    Eur J Surg Oncol; 2018 Aug; 44(8):1199-1204. PubMed ID: 29784506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of two prognostic nomograms for predicting survival in patients with non-small cell and small cell lung cancer.
    Xiao HF; Zhang BH; Liao XZ; Yan SP; Zhu SL; Zhou F; Zhou YK
    Oncotarget; 2017 Sep; 8(38):64303-64316. PubMed ID: 28969072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment.
    Liang W; Shen G; Zhang Y; Chen G; Wu X; Li Y; Li A; Kang S; Yuan X; Hou X; Huang P; Huang Y; Zhao H; Tian Y; Zhao C; Zhang L
    Chin J Cancer; 2016 Nov; 35(1):98. PubMed ID: 27887636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Nomogram for Predicting Cancer-Specific Survival of TNM 8th Edition Stage I Non-small-cell Lung Cancer.
    Zeng Y; Mayne N; Yang CJ; D'Amico TA; Ng CSH; Liu CC; Petersen RH; Rocco G; Brunelli A; Liu J; Liu Y; Huang W; He J; Wang W; Jiang L; Cui F; Wang W; Liang W; He J;
    Ann Surg Oncol; 2019 Jul; 26(7):2053-2062. PubMed ID: 30900105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery.
    Mao Q; Xia W; Dong G; Chen S; Wang A; Jin G; Jiang F; Xu L
    J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1784-1792.e3. PubMed ID: 29554790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of nomogram combining serum biomarker for predicting survival in patients with resected rectal cancer.
    Fan S; Li T; Zhou P; Peng Q; Zhu Y
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External Validation of a Survival Nomogram for Non-Small Cell Lung Cancer Using the National Cancer Database.
    Young KA; Efiong E; Dove JT; Blansfield JA; Hunsinger MA; Wild JL; Shabahang MM; Facktor MA
    Ann Surg Oncol; 2017 Jun; 24(6):1459-1464. PubMed ID: 28168388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a new clinical staging system to predict survival for esophageal squamous cell carcinoma patients: Application of the nomogram.
    Shao CY; Liu XL; Yao S; Li ZJ; Cong ZZ; Luo J; Dong GH; Yi J
    Eur J Surg Oncol; 2021 Jun; 47(6):1473-1480. PubMed ID: 33349524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung.
    Li H; Wang Z; Yang F; Wang J
    J Surg Oncol; 2020 May; 121(6):1027-1035. PubMed ID: 32026478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The advanced lung cancer inflammation index (ALI) predicted the postoperative survival rate of patients with non-small cell lung cancer and the construction of a nomogram model.
    Ma S; Li Z; Wang L
    World J Surg Oncol; 2024 Jun; 22(1):158. PubMed ID: 38877553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a nomogram for predicting survival in Chinese han patients with resected colorectal cancer.
    Li J; Gu J; Ma X; Li X; Liu X; Kang F; Xue F
    J Surg Oncol; 2018 Nov; 118(6):1034-1041. PubMed ID: 30196534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of metastatic lymph nodes ratio in overall survival for patients with resected nonsmall cell lung cancer: a retrospective cohort study.
    Lin X; Yao J; Huang B; Chen T; Xie L; Huang R
    Eur J Cancer Prev; 2024 Jul; 33(4):376-385. PubMed ID: 38842873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a nomogram for predicting overall survival of resected N2 non-small cell lung cancer patients undergoing neoadjuvant radiotherapy.
    Shi J; Peng B; Wang C; Zhou X; Lu T; Xu R; Chang X; Shen Z; Wang K; Xu C; Zhang L
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11779-11790. PubMed ID: 37407846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An inflammation-related nomogram for predicting the survival of patients with non-small cell lung cancer after pulmonary lobectomy.
    Wang Y; Qu X; Kam NW; Wang K; Shen H; Liu Q; Du J
    BMC Cancer; 2018 Jun; 18(1):692. PubMed ID: 29940884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of a Nomogram Prognostic Model for Resected Limited-Stage Small Cell Lung Cancer Patients.
    Zeng Q; Li J; Tan F; Sun N; Mao Y; Gao Y; Xue Q; Gao S; Zhao J; He J
    Ann Surg Oncol; 2021 Sep; 28(9):4893-4904. PubMed ID: 33655361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and Validation of Nomogram Model Integrated With Inflammation-Based Factors for the Prognosis of Advanced Non-Small Cell Lung Cancer.
    Huang Z; Xing S; Zhu Y; Qu Y; Jiang L; Sheng J; Wang Q; Xu S; Xue N
    Technol Cancer Res Treat; 2020; 19():1533033820971605. PubMed ID: 33191854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and external validation of a nomogram to predict overall survival following stereotactic body radiotherapy for early-stage lung cancer.
    Baker S; Bakunina K; Duijm M; Hoogeman MS; Cornelissen R; Antonisse I; Praag J; Heemsbergen WD; Nuyttens JJ
    Radiat Oncol; 2020 Apr; 15(1):89. PubMed ID: 32321553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram prediction of overall survival for patients with non-small-cell lung cancer incorporating pretreatment peripheral blood markers.
    Xie D; Allen MS; Marks R; Jiang G; Sun Z; Nichols F; Zhang M; Chen C; Aubry MC; Jatoi A; Garces YI; Mansfield A; Wigle D; Molina J; Deschamps C; Yang P
    Eur J Cardiothorac Surg; 2018 Jun; 53(6):1214-1222. PubMed ID: 29293957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.